| Name | Title | Contact Details |
|---|
abeo is a nationwide medical billing and software company focused on delivering revenue-enhancing services to private practices, hospitals and surgery centers. We bridge the gap between the constant change in healthcare and your changing needs as a result. We know the healthcare landscape; we know the complexities and regulations. Our professional management services, medical billing software and anesthesia advisory services are tailored to improve the operational and financial performance for the specialty of anesthesiology. We blend our employee expertise in anesthesia with process and technology to take efficiency to the next level. Operational best practices play a key role in our ability to provide the quality of service clients receive and have come to expect from abeo. Our clients know their best interest is at the center of abeo doing their job, and doing it well.
Health Education Alliance is a White Plains, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Salud Dorada con Medicare is a Bayamon, PR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Myelin Health is a network of companies linked by their experience and capabilities in the healthcare space. For payer and provider organizations, we create connections that make the most powerful messages mean even more. Myelin Health operates a strong and collaborative system of communication experts with capabilities in creative digital and traditional solutions, strategy and branding concepts, integrated marketing and advertising content, research, data and analytics, mobile engagement, design and more.
At Catabasis Pharmaceuticals, our mission is to bring hope and life-changing therapies to patients and their families. Our SMART (Safely Metabolized And Rationally Targeted) Linker drug discovery platform enables us to engineer molecules that simultaneously modulate multiple targets in a disease. We are applying our SMART LinkerSM platform to build an internal pipeline of product candidates for rare diseases and plan to pursue partnerships to develop additional product candidates.